Chi­na to cut can­cer drug prices; Nim­bus nabs Gilead­'s Adri­an Ray to serve as SVP of dis­cov­ery bi­ol­o­gy

Chi­na’s med­ical in­sur­ance au­thor­i­ties are pledg­ing to slash can­cer drug prices, ac­cord­ing to a week­end re­port from the Com­mu­nist par­ty-run Peo­ple’s Dai­ly. Drugs al­ready …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.